European Foulbrood: The Brood Disease That Fools

The name is misleading twice. "European" suggests the disease is a European problem, which it isn't - it's global, found on every continent where honey bees are kept. "Foulbrood" suggests it smells like American foulbrood, which it usually doesn't - EFB produces a sour or yeasty odor at best, nothing like the distinctive rotting-fish stench of AFB that experienced beekeepers can identify from several feet away.

European foulbrood (EFB) is the other bacterial brood disease. The less famous one. The one that doesn't require burning the hive. The one that strong colonies can sometimes fight off on their own. The "sometimes" in that sentence has been the source of more misjudged management decisions than perhaps any other word in apicultural pathology.

The Bacterium

The causative agent is Melissococcus plutonius, a lanceolate (lance-shaped) gram-positive coccus that was first described by White in 1912 and has been reclassified multiple times since. It's a strict anaerobe (or microaerophilic - it tolerates but doesn't thrive in oxygen), which is relevant because it lives and reproduces inside the anaerobic environment of the larval gut.

Infection occurs through feeding. Nurse bees inadvertently deliver M. plutonius spores (or vegetative cells - the bacterium persists in both forms) to young larvae along with the brood food they produce. The bacteria colonize the larval midgut, competing with the larva for nutrients. In severe infections, the bacteria overwhelm the larva's digestive system, starving it of nutrition. The larva dies - typically at 4 to 5 days old, before the cell is capped.

This timing is the key diagnostic distinction from AFB. American foulbrood kills larvae after capping - the dead larva is found beneath a sealed cell cap that is often sunken, dark, or perforated. European foulbrood kills larvae before capping (usually) - the dead larva is found in an open cell, visible without removing caps.

The dead larva has a characteristic appearance: twisted or corkscrewed in the cell (instead of the normal curled "C" shape of a healthy larva), discolored from white to yellow to brown, and deflated. In advanced cases, the larva dries to a rubbery scale on the cell wall - but unlike AFB scales, EFB scales are not ropy (they don't stretch into a thread when probed with a matchstick) and are easier to remove from the cell.

The Confusion

The textbook description of EFB - dead uncapped larvae, corkscrewed, yellow-brown, sour smell - is clear enough. The problem is that textbook presentations are not what beekeepers usually encounter. In practice, EFB diagnosis is complicated by:

Mixed infections. M. plutonius rarely acts alone. Secondary bacterial invaders - particularly Paenibacillus alvei, Enterococcus faecalis, and Brevibacillus laterosporus - commonly colonize larvae already weakened by M. plutonius, altering the visual presentation and smell. The "sour" odor of classic EFB is often masked or modified by secondary infections.

Late-stage EFB that mimics AFB. In some cases, EFB-infected larvae survive until after capping and die as prepupae - inside sealed cells. These dead prepupae can look superficially similar to AFB: sunken caps, discolored remains. The ropy test (pulling the remains with a matchstick to see if they stretch) can help distinguish - AFB produces a characteristic rope of 1 to 2 centimeters; EFB remains are watery or rubbery and don't rope - but in field conditions, the distinction can be ambiguous.

Chalkbrood co-occurrence. Chalkbrood (fungal) and EFB (bacterial) often appear in the same colony because both are associated with stress, poor nutrition, and damp conditions. Seeing chalkbrood mummies alongside EFB-symptomatic larvae requires the beekeeper to recognize two diseases simultaneously.

Subclinical infection. Colonies can carry M. plutonius without showing clinical symptoms. The bacteria persist in the hive environment - in stored pollen (bee bread), on comb surfaces, in honey - at levels too low to cause visible disease in a strong colony. When the colony is stressed (poor nutrition, weather event, Varroa load, queenlessness), the subclinical infection can flare into clinical disease. This makes EFB seem to "appear out of nowhere" in hives that were apparently healthy.

The Self-Limiting Question

The textbook says EFB is self-limiting in strong colonies. The logic: a strong colony with a productive queen can produce new brood faster than the disease kills larvae. The hygienic behavior of adult bees - detecting and removing diseased larvae from cells - also helps suppress the infection. As the nectar flow strengthens and the colony builds up in spring, the colony "outgrows" the disease.

This happens. It's real. Many EFB infections resolve without intervention when conditions improve.

It also doesn't always happen. Colonies that are weakened by other stressors - Varroa, poor nutrition, cold spring weather that delays buildup, an aging or failing queen - may not outgrow the infection. In these colonies, EFB becomes a death spiral: the disease kills brood, which reduces the adult population, which reduces the colony's ability to feed and care for the remaining brood, which allows the infection to spread further.

The decision of whether to treat or wait - to trust the colony's resilience or intervene with antibiotics - is one of the more difficult judgment calls in bee disease management. It requires assessing the colony's overall strength, the severity of the infection, the time of season, and the availability of incoming forage. A strong colony with mild EFB in May will probably recover. A marginal colony with severe EFB in April probably won't.

The Treatment

For decades, the standard treatment for EFB was oxytetracycline (OTC), sold under the brand name Terramycin. OTC is a broad-spectrum antibiotic that suppresses M. plutonius (and the secondary invaders) in the colony. It's mixed with powdered sugar and dusted onto the top bars of frames, where bees consume it during food exchange. The treatment doesn't kill the bacteria - it's bacteriostatic, meaning it stops bacterial reproduction. The colony's hygienic behavior does the actual cleanup.

OTC worked. It was cheap, readily available at beekeeping supply stores, and effective when applied correctly (three treatments at 4-to-5-day intervals, with honey supers removed to prevent antibiotic contamination of marketable honey).

In January 2017, the FDA's Veterinary Feed Directive (VFD) took effect, reclassifying OTC and other medically important antibiotics used in food-producing animals. Under the VFD, OTC for honey bees requires a prescription or veterinary feed directive from a licensed veterinarian. Beekeepers can no longer purchase OTC over the counter at the feed store.

The intent of the VFD was to reduce the development of antibiotic-resistant bacteria by ensuring veterinary oversight of antibiotic use in food-producing animals. The intent was sound. The practical effect on beekeeping was complicated.

The problem: there are very few veterinarians in the US with expertise in honey bee health. The American Association of Honey Bee Veterinarians (AAHBV), formed in response to the VFD, has worked to train veterinarians in bee medicine. But in many areas, particularly rural regions, beekeepers found themselves unable to obtain OTC because no local veterinarian was willing or able to prescribe it for bees. A hobbyist beekeeper with two hives in rural Montana facing an EFB outbreak might be 200 miles from the nearest veterinarian with bee experience.

The VFD created a de facto treatment gap for EFB. Some beekeepers have established relationships with bee-knowledgeable veterinarians. Others have resorted to requeening (replacing the queen to break the brood cycle and give the colony a fresh start) and colony management (shaking bees onto new foundation to remove contaminated comb) as non-antibiotic interventions. These methods work - but they're more labor-intensive and less reliable than OTC treatment.

The Reportability

In most US states, EFB is a reportable disease - meaning beekeepers are legally required to notify their state apiarist if they suspect or confirm an EFB infection. In practice, reporting is inconsistent. Hobbyist beekeepers may not know about reporting requirements. The consequences of reporting vary by state - some states send inspectors to confirm the diagnosis and provide management guidance; others have no enforcement capacity.

EFB is not subject to the same regulatory severity as AFB. No state requires burning of EFB-infected equipment (as many states do for AFB). The equipment can be cleaned - scraping, scorching with a propane torch, or irradiation - and reused. The regulatory distinction reflects the biological reality: EFB is less persistent in equipment than AFB (whose bacterial spores survive for decades in comb), and the disease is more amenable to management without total destruction.

However, the distinction can lead to under-response. A colony with EFB that's left to "self-limit" but instead deteriorates becomes a source of contaminated comb and honey that, if robbed by other colonies during a dearth, spreads the infection to neighboring hives. The self-limiting nature of EFB is a central fact of the disease's biology, but relying on it without monitoring is how localized infections become apiary-wide outbreaks.

The Diagnostic Tools

Field diagnosis of EFB is based on visual inspection and - where available - simple tests:

Visual inspection. The presence of dead or dying larvae in uncapped cells, with the characteristic corkscrewed posture and yellow-brown discoloration, is suggestive. But visual inspection alone has a high false-positive rate - nutritional deficiency, pesticide damage, and other brood diseases can produce similar-looking dead larvae.

The smell test. Classic EFB has a sour, vinegar-like odor. But the smell is inconsistent, varies with secondary infections, and is absent in mild cases. Relying on smell alone misses many infections.

Lateral flow devices. Rapid diagnostic test kits (similar in principle to COVID rapid tests) that detect M. plutonius proteins in larval samples are available. These kits provide results in minutes with reasonable sensitivity and specificity. They're the most reliable field diagnostic tool but cost $8 to $15 per test and are not widely used by hobbyist beekeepers.

Laboratory culture. The definitive diagnosis: larval samples are sent to a diagnostic laboratory (the USDA Bee Research Laboratory in Beltsville, Maryland accepts samples from US beekeepers at no charge) for bacterial culture and identification. Results take 1 to 3 weeks but are conclusive.

The Ecology

EFB is not just a disease of management failure. It has an ecological dimension that connects it to the broader stressors affecting honey bee colonies.

The disease is more prevalent and more severe in areas with poor forage diversity - where colonies depend on a single nectar and pollen source that may be nutritionally inadequate. Protein-deficient pollen leads to protein-deficient brood food, which leads to larvae with compromised immune function, which leads to higher susceptibility to bacterial infection. EFB outbreaks often coincide with periods of nutritional stress - early spring before the main nectar flow, or in agricultural monocultures where diverse forage is lacking.

The disease is also associated with wet, cool spring weather - conditions that confine bees to the hive, reduce foraging, and create the damp, warm environment that M. plutonius favors. Climate variability that produces late cold snaps and extended wet periods in spring may be increasing EFB incidence, though the data is insufficient to confirm a trend.

EFB is, in this sense, a sentinel disease - an indicator that something in the colony's environment is suboptimal. A strong colony with good nutrition in a diverse forage landscape rarely develops clinical EFB, even if M. plutonius is present at subclinical levels. A stressed colony in a poor forage environment with high mite loads and weather challenges gets EFB because its defenses are already overwhelmed.

The bacterium exploits weakness. The weakness comes from everywhere else.